Welcome to our dedicated page for Ethema Hlth SEC filings (Ticker: GRST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page is intended to provide access to U.S. regulatory filings for Ethema Health Corporation (OTCPINK: GRST), a behavioral healthcare company focused on the treatment of substance use disorders. Ethema operates through its ARIA (Addiction Recovery Institute of America) subsidiary and managed operations in Florida and Kentucky, and it references SEC reporting such as a Form 10-Q in its public news releases.
For a company like Ethema, key filings typically include annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe financial performance, operating results of treatment centers, and developments in subsidiaries such as ARIA and operations associated with Edgewater Recovery Center in Kentucky. Filings may also include current reports on Form 8-K that document material events, such as letters of intent, management agreements, or asset purchase agreements related to behavioral health facilities.
Investors often review proxy or information statements for details on governance and compensation, and Form 4 filings for information on transactions by officers, directors, or significant shareholders, where applicable. These documents can help readers understand how Ethema’s behavioral health operations, licensing milestones, and real estate-related strategies affect its financial position and capital structure.
On Stock Titan, Ethema Health Corporation filings are supplemented with AI-powered summaries that highlight important sections and explain complex disclosures in simpler language. As new filings are made available through EDGAR, this page is updated so users can quickly see and interpret the latest regulatory information related to GRST.
Ethema Health Corporation reported sharply higher activity for the quarter ended September 30, 2025, driven by its expanded addiction treatment footprint. Quarterly revenue rose to $5.53 million from $1.76 million a year earlier, helped by the January 2025 acquisition of Edgewater Recovery Centers’ Kentucky operations. For the first nine months of 2025, revenue reached $13.95 million versus $4.55 million in the prior-year period.
Operating income for the quarter was $546,015, compared with an operating loss a year ago, and net income was $66,136, though the company still recorded a $1.11 million net loss year‑to‑date. The Edgewater transaction added customer relationships, licenses and other intangibles, plus $3.49 million of goodwill, and was funded in part by new bank debt, including a $4.25 million promissory note.
Ethema’s balance sheet remains highly leveraged. At September 30, 2025, total liabilities of $38.84 million exceeded total assets of $30.27 million, with a working capital deficit of about $12.2 million, an accumulated deficit of $45.5 million, and cash of $114,030. Management states these conditions raise substantial doubt about the company’s ability to continue as a going concern and indicates it will need additional capital and continued revenue growth to support operations.